Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 26, No 21 (July 20), 2008: pp. 3530-3535
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2007.15.5630

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Olson, J. A.
Right arrow Articles by Giuliano, A. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olson, J. A., Jr
Right arrow Articles by Giuliano, A. E.
Related Articles
Right arrowRelated Editorial

Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011

John A. Olson, Jr, Linda M. McCall, Peter Beitsch, Pat W. Whitworth, Douglas S. Reintgen, Peter W. Blumencranz, A. Marilyn Leitch, Sukamal Saha, Kelly K. Hunt, Armando E. Giuliano

From the Department of Surgery, Duke University Medical Center, Durham, NC; University of Texas Southwestern Medical Center; Dallas Surgical Group, Dallas; The University of Texas M.D. Anderson Cancer Center, Houston, TX; Nashville Breast Center, Nashville, TN; Lakeland Regional Cancer Center, Lakeland; Surgical Associates of West Florida, Clearwater, FL; Advanced Surgical Associates, Flint, MI; and the John Wayne Cancer Institute, Santa Monica, CA

Corresponding author: John A. Olson Jr, MD, PhD, Box 3873, Duke University Medical Center, Durham, NC 27710; e-mail: jaomd{at}duke.edu

Purpose: Patients with breast cancer metastasis to the sentinel lymph nodes (SLNs) generally undergo completion axillary lymph node dissection (cALND), either concurrently with SLN biopsy or at a second procedure. The impact of the timing of cALND on pathologic results and complications in these patients has not been examined.

Patients and Methods: We examined outcomes from SLN-positive patients in American College of Surgeons Oncology Group (ACOSOG) trials Z0010 and Z0011. Pathologic data examined included primary tumor characteristics, total number of SLNs recovered, positive SLN(s) and non-SLN(s) identified. Complications assessed included axillary seroma, paresthesia, arm morbidity and range of motion, and lymphedema.

Results: A total of 1,003 assessable patients with SLN metastasis had immediate (n = 425) or delayed (n = 578) cALND. The median number of SLNs and axillary LNs removed were the same between groups. Patients who had immediate cALND more often had larger tumors, SLN metastasis identified intraoperatively, two or more positive SLNs, and higher pathologic N stage. Axillary paresthesia, seroma, and impaired extremity range of motion were more common in the immediate group during the early postoperative period, but not at later time points. There was no difference in lymphedema at any time point.

Conclusion: In ACOSOG trials Z0010 and Z0011, LN recovery and long-term complications were similar after either delayed or immediate cALND for patients with metastasis to SLNs. Patients who undergo immediate cALND experience more short-term morbidity. With respect to staging and complications, there is no clear detriment for patients with a positive SLN who undergo a second procedure for cALND.

Supported by Grant No. U10-CA76001-11 from the National Cancer Institute, Bethesda, MD.

Presented at the 60th Annual Cancer Symposium of the Society of Surgical Oncology, March 15-18, 2007, Washington, DC.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.

Clinical Trials repository link available on www.JCO.org.


Related Editorial

  • Completion Axillary Lymph Node Dissection for Breast Cancer: Immediate Versus Delayed Versus None
    Harry D. Bear
    JCO 2008 26: 3483-3484 [Full Text]


This article has been cited by other articles:


Home page
JCOHome page
H. D. Bear
Completion Axillary Lymph Node Dissection for Breast Cancer: Immediate Versus Delayed Versus None
J. Clin. Oncol., July 20, 2008; 26(21): 3483 - 3484.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online